Scout Investments Inc. lowered its stake in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 1.5% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 282,400 shares of the specialty pharmaceutical company’s stock after selling 4,429 shares during the period. Scout Investments Inc. owned approximately […]
Lazard Asset Management LLC increased its position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 170.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 11,905 shares of the specialty pharmaceutical company’s stock after purchasing an additional 7,508 shares […]
Polar Capital Holdings Plc raised its holdings in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 10.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,654,470 shares of the specialty pharmaceutical company’s stock after acquiring an additional 150,000 […]
Rice Hall James & Associates LLC Trims Position in Supernus Pharmaceuticals, Inc (NASDAQ:SUPN) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
StockNews.com upgraded shares of Supernus Pharmaceuticals (NASDAQ:SUPN – Free Report) from a hold rating to a buy rating in a report released on Wednesday. Separately, Piper Sandler raised their price target on shares of Supernus Pharmaceuticals from $42.00 to $43.00 and gave the company an overweight rating in a research report on Thursday, November 9th. […]